257 related articles for article (PubMed ID: 16575388)
1. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion.
Schön MP; Schön M; Klotz KN
J Invest Dermatol; 2006 Jun; 126(6):1338-47. PubMed ID: 16575388
[TBL] [Abstract][Full Text] [Related]
2. TLR7 and TLR8 as targets in cancer therapy.
Schön MP; Schön M
Oncogene; 2008 Jan; 27(2):190-9. PubMed ID: 18176600
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod: mode of action.
Schön MP; Schön M
Br J Dermatol; 2007 Dec; 157 Suppl 2():8-13. PubMed ID: 18067624
[TBL] [Abstract][Full Text] [Related]
4. The antitumoral mode of action of imiquimod and other imidazoquinolines.
Schön M; Schön MP
Curr Med Chem; 2007; 14(6):681-7. PubMed ID: 17346155
[TBL] [Abstract][Full Text] [Related]
5. Roles of TLR7 in activation of NF-κB signaling of keratinocytes by imiquimod.
Li ZJ; Sohn KC; Choi DK; Shi G; Hong D; Lee HE; Whang KU; Lee YH; Im M; Lee Y; Seo YJ; Kim CD; Lee JH
PLoS One; 2013; 8(10):e77159. PubMed ID: 24146965
[TBL] [Abstract][Full Text] [Related]
6. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
7. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod.
Schön MP; Schön M
Apoptosis; 2004 May; 9(3):291-8. PubMed ID: 15258460
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides.
Gorden KK; Qiu XX; Binsfeld CC; Vasilakos JP; Alkan SS
J Immunol; 2006 Nov; 177(10):6584-7. PubMed ID: 17082568
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway.
Kan Y; Okabayashi T; Yokota S; Yamamoto S; Fujii N; Yamashita T
J Virol; 2012 Oct; 86(19):10338-46. PubMed ID: 22787201
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
Urosevic M; Oberholzer PA; Maier T; Hafner J; Laine E; Slade H; Benninghoff B; Burg G; Dummer R
Clin Cancer Res; 2004 Aug; 10(15):4959-70. PubMed ID: 15297396
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
Butchi NB; Pourciau S; Du M; Morgan TW; Peterson KE
J Immunol; 2008 Jun; 180(11):7604-12. PubMed ID: 18490763
[TBL] [Abstract][Full Text] [Related]
12. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis.
Flutter B; Nestle FO
Eur J Immunol; 2013 Dec; 43(12):3138-46. PubMed ID: 24254490
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation.
Wolff F; Loipetzberger A; Gruber W; Esterbauer H; Aberger F; Frischauf AM
Oncogene; 2013 Dec; 32(50):5574-81. PubMed ID: 23995793
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
[TBL] [Abstract][Full Text] [Related]
15. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.
Vasilakos JP; Tomai MA
Expert Rev Vaccines; 2013 Jul; 12(7):809-19. PubMed ID: 23885825
[TBL] [Abstract][Full Text] [Related]
16. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
17. Gene expression in actinic keratoses: pharmacological modulation by imiquimod.
Lysa B; Tartler U; Wolf R; Arenberger P; Benninghoff B; Ruzicka T; Hengge UR; Walz M
Br J Dermatol; 2004 Dec; 151(6):1150-9. PubMed ID: 15606509
[TBL] [Abstract][Full Text] [Related]
18. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
19. The duck toll like receptor 7: genomic organization, expression and function.
MacDonald MR; Xia J; Smith AL; Magor KE
Mol Immunol; 2008 Apr; 45(7):2055-61. PubMed ID: 18036663
[TBL] [Abstract][Full Text] [Related]
20. Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
Zhu J; Lai K; Brownile R; Babiuk LA; Mutwiri GK
Mol Immunol; 2008 Jun; 45(11):3238-43. PubMed ID: 18439678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
